Literature DB >> 24294570

Intact canal wall tympanomastoid surgery: 10 years experience.

Nishi Sonkhya1, Payal Mittal, Divij Sonkhya.   

Abstract

310 cases of chronic middle ear disease were managed by Intact canal wall tympanomastoid surgery. Intact canal wall tympanomastoid surgery technique used in this study has been compared with the Jansen's classic ICW technique. A retrospective analysis of 310 cases of chronic middle ear pathology managed by Intact canal wall technique over a period of 10 years (January 1996 to December 2005) was conducted. Patients information was collected from the patients record. 310 patients, aged 5-60 years, were managed by Intact canal wall technique and followed for a minimum period of 5 years. The male:female ratio in our study was 1.25:1 (172 males:138 females). The ratio of adult to pediatric patients was 2.7:1 (226 adults:84 children). Out of 274 (88.4%) cases having a regular follow up, 196 (71.6%) were found to be stable. Postoperative retraction of the tympanic membrane was observed in 24 (8.8%) cases and was managed by the placement of ventilation tube. Secretory otitis media was seen in 14 (5%) cases and was managed by myringotomy and placement of ventilation tube. 17(12.4%) cases were revised including recurrent disease (10 cases), residual disease (6 cases), graft failure (12 cases), stenosis of the ear canal (4 cases), meatomastoid fistula (2 case). Our technique of Intact canal wall tympanomastoid surgery takes less time than the classic Jansen's technique, is easily reproducible and taught, is a single stage procedure and can be universally applied to various chronic middle ear pathologies as the primary treatment with low recidivism rate.

Entities:  

Keywords:  Chronic middle ear pathology; Intact canal wall technique; Tympanomastoid surgery

Year:  2011        PMID: 24294570      PMCID: PMC3477432          DOI: 10.1007/s12070-011-0298-3

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  30 in total

1.  Canal wall down tympanoplasty with canal reconstruction for middle-ear cholesteatoma: post-operative hearing, cholesteatoma recurrence, and status of re-aeration of reconstructed middle-ear cavity.

Authors:  Minoru Ikeda; Shinya Yoshida; Akihiro Ikui; Shuntaro Shigihara
Journal:  J Laryngol Otol       Date:  2003-04       Impact factor: 1.469

2.  Cholesteatoma surgery: residual and recurrent disease. A review of 1,024 cases.

Authors:  J L Sheehy; D E Brackmann; M D Graham
Journal:  Ann Otol Rhinol Laryngol       Date:  1977 Jul-Aug       Impact factor: 1.547

3.  The canal wall in tympanoplasty and mastoidectomy.

Authors:  J B Farrior
Journal:  Arch Otolaryngol       Date:  1969-12

Review 4.  Chronic otitis media with epidermoid cholesteatoma. A discussion of some points of controversy concerning surgical management.

Authors:  R E Gristwood
Journal:  Clin Otolaryngol Allied Sci       Date:  1976

5.  Treatment of retraction pockets and cholesteatoma.

Authors:  J Sadé
Journal:  J Laryngol Otol       Date:  1982-08       Impact factor: 1.469

6.  Intact canal wall tympanoplasty with mastoidectomy. A review of eight years' experience.

Authors:  J L Sheehy; M E Patterson
Journal:  Laryngoscope       Date:  1967-08       Impact factor: 3.325

7.  Transcanal atticoaditotomy and transcortical mastoidectomy for cholesteatoma: the Farrior-Olaizola technique revisited.

Authors:  T N Reddy; S N Dutt; A Shetty; S Maini
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-08       Impact factor: 1.547

8.  Closed tympanoplasty in middle ear cholesteatoma surgery.

Authors:  Eugenijus Lesinskas; Vija Vainutiene
Journal:  Medicina (Kaunas)       Date:  2004       Impact factor: 2.430

9.  Modification of combined-approach tympanoplasty in attic cholesteatoma.

Authors:  M Tos
Journal:  Arch Otolaryngol       Date:  1982-12

10.  A ten year statistical follow-up of 1142 consecutive cases of cholesteatoma: the closed vs. the open technique.

Authors:  J S Brown
Journal:  Laryngoscope       Date:  1982-04       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.